March 13, 2001
Biomerica Inc., a Newport Beach medical technology company, said Monday that the Japanese Ministry of Health has approved the company's disposable prostrate cancer screening test for distribution and marketing. The company said in a press release that the 10-minute test is designed to detect elevated blood levels of prostate specific antigen, an early warning indicator of prostate cancer.
September 15, 2000
Biomerica Inc., a Newport Beach medical technology company, said it lost $3.9 million, or 86 cents a share, for its fiscal year ended May 31, compared with a year-earlier net loss of $72,548, or 2 cents a share. Revenue fell 8% to $8 million. The company did not break out fourth-quarter results.
August 17, 2000 |
Biomerica Inc. said it has developed a test that helps detect and monitor the presence of peptic ulcers and stomach cancer. The Newport Beach medical technology company said the test measures the amounts of Pepsinogen-1 present in human serum, which can mark the presence of a peptic ulcer. The test can also be used to measure the effectiveness of treatments.
March 22, 2000 |
Biomerica Inc., a Newport Beach maker of medical diagnostic products, said Tuesday it signed a two-year exclusive agreement with Sentinel CH, an Italian medical diagnostic product distributor, to market and distribute Biomerica's Allerquant Med90 food allergy kit in Italy. Financial terms weren't disclosed. Biomerica's stock slipped 6 cents a share to $3.09 in Nasdaq trading.